In today’s news Jazz Pharmaceuticals (JAZZ) announced the submission of a Marketing Authorization Application (MAA) to the European …

RegenxBio (RGNX) has granted Abeona Therapeutics (ABEO) an exclusive worldwide license to its NAV AAV9 viral vector (subject …

Exelixis (EXEL) provided an update that testified to its solid fundamentals, the growth of its approved …

A number of biotech or biopharmaceutical companies have succeeded in the past couple of years in …

Although the tests are for the prevention of a life-threatening metabolic disorder, the prenatal animal testing …

IMMUNOTHERAPY  The Checkpoint Inhibitors The most revered news was the discovery of the checkpoint proteins on …

Why Portola’s Stock Decline Everybody interested in Portola (PTLA) knows by now that this firm has managed …

In two pivotal Phase 3 placebo-controlled trials Regeneron Pharmaceuticals’ (REGN) and Sanofi’s (SNY) drug, Dupixent® (dupilumab), demonstrated a …

Prohost Letter #424 Following the Stars Less Science and More Logic We reiterate that while a …

On Saturday, October 6, 2018, Spark Therapeutics (ONCE) presented positive data from a preclinical trial with SPK-3006 …